Racial and Ethnic Disparities and Facility-Level Variation in GLP-1 RA Prescription among US Veterans with CKD-Reference-Cited by-同舟云学术

Racial and Ethnic Disparities and Facility-Level Variation in GLP-1 RA Prescription among US Veterans with CKD

Published:2023-07-25 Issue:11 Volume:18 Page:1479-1482
ISSN:1555-9041
Container-title:Clinical Journal of the American Society of Nephrology
language:en
Short-container-title:CJASN

Author:

Gregg L. Parker¹²³,Worsley Melandrea L.¹^ORCID,Ramsey David J.³^ORCID,Segar Matthew W.⁴^ORCID,Matheny Michael E.⁵⁶^ORCID,Virani Salim S.⁴⁷^ORCID,Navaneethan Sankar D.¹³⁸⁹

Affiliation:

1. Section of Nephrology, Baylor College of Medicine, Selzman Institute for Kidney Health, Houston, Texas

2. Research Service Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas

3. Michael E. DeBakey VA Medical Center Health Services Research and Development, Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas

4. Department of Cardiology, Texas Heart Institute, Houston, Texas

5. Geriatrics Research Education and Clinical Care Service, Tennessee Valley Healthcare System VA, Nashville, Tennessee

6. Departments of Biomedical Informatics, Biostatistics, and Medicine, Vanderbilt University Medical Center, Nashville, Tennessee

7. Aga Khan University, Karachi, Pakistan

8. Renal Section, Medical Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas

9. Institute of Clinical and Translational Research, Baylor College of Medicine, Houston, Texas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology

Reference7 articles.

1. KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease;de Boer;Kidney Int.,2020

2. Prescription patterns of cardiovascular- and kidney-protective therapies among patients with type 2 diabetes and chronic kidney disease;Lamprea-Montealegre;Diabetes Care.,2022

3. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Arnett;Circulation.,2019

4. Predictors, disparities, and facility-level variation: SGLT2 inhibitor prescription among US veterans with CKD;Gregg;Am J Kidney Dis.,2023

5. Association of race and ethnicity with prescription of SGLT2 inhibitors and GLP1 receptor agonists among patients with type 2 diabetes in the Veterans Health Administration system;Lamprea-Montealegre;JAMA.,2022